NEOS Surgery

NEOS Surgery

Barcelona, Spain· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $12M

Overview

NEOS Surgery is a private, commercial-stage medical device company developing and selling innovative surgical solutions for cranial, spinal, and cardiothoracic applications. Its core commercial products include the STERN FIX sternal stabilization system, the Cranial LOOP PEEK fixation device, and the Cranial COVER burr hole cover. The company is actively engaged in R&D, with projects like DISC care advancing through clinical studies, and has an established international presence through a distributor network, supported by past European funding initiatives.

NeurosurgerySpine SurgeryCardiothoracic Surgery

Technology Platform

Expertise in advanced biocompatible materials (PEEK, carbon fiber) for designing ultra-low profile, instrument-free, and CT/MRI artifact-free surgical implants for cranial, spinal, and sternal fixation.

Funding History

2
Total raised:$12M
Series A$10M
Seed$2M

Opportunities

Growing demand for artifact-free, patient-friendly implants in neurosurgery and the shift from wires to rigid plating in high-risk sternal closures present significant market opportunities.
Expansion into the large spinal surgery market with the DISC care device could drive major growth if clinical and regulatory milestones are met.

Risk Factors

Intense competition from large, established medtech companies and the challenge of changing entrenched surgical practices pose significant market risks.
Regulatory delays or clinical setbacks with key pipeline programs like DISC care could impact growth trajectories and financial stability.

Competitive Landscape

NEOS competes in niche segments against giants like Medtronic, Stryker, and Johnson & Johnson's DePuy Synthes, as well as other specialist firms. Its differentiation is based on specialized material science (PEEK, carbon fiber) offering specific advantages like MRI compatibility and low profile, rather than competing on a full portfolio basis.